BioMarin Signs Fabry Disease Treatment Development Deal
BioMarin signed an agreement with GC Biopharma and Hanmi to develop a treatment for Fabry disease.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.